文献速递焦虑、强迫与应激相关障碍

阿片拮抗对健康志愿者外显与内隐威胁加工功能磁共振相关的影响

Effects of opioid antagonism on functional MRI correlates of explicit and implicit threat processing in healthy volunteers.
PubMed 文献 · Br J Psychiatry · 2026-04-16

该随机双盲安慰剂对照交叉设计纳入38名健康志愿者,在功能磁共振下完成认知情绪重评任务和面孔观看任务,评估纳曲酮50mg对威胁刺激加工的影响。结果显示纳曲酮降低重评任务中的痛苦评分(p=0.044)且未损害调节成功,同时减弱负性图片诱发的腹内侧前额叶、丘脑和尾状核激活,并改变情绪面孔加工相关脑区活动。结论支持阿片信号参与自动情绪调节而非外显调节。

要点

  • 纳曲酮降低重评任务痛苦评分(p=0.044)且未损害调节成功。
  • 纳曲酮减弱负性图片诱发的腹内侧前额叶、丘脑和尾状核激活。
  • 纳曲酮增加观看恐惧面孔时左侧额中回活动。

核心结论

  • 结果支持阿片信号参与自动情绪调节,但不参与外显调节。
  • 纳曲酮似乎减弱任务阳性区域对情绪面孔的反应。
  • 内源性阿片类物质可能对负性和正性刺激的情感反应进行微调。

研究设计与样本

  • 随机、双盲、安慰剂对照、交叉设计。
  • 38名健康参与者接受纳曲酮50 mg或安慰剂。
  • 在功能磁共振成像下完成认知情绪重评任务和面孔观看任务。

主要发现

  • 纳曲酮降低重评任务中的痛苦评分(p=0.044),且未损害调节成功。
  • 重评任务中的外显调节在药物条件下相似地激活外侧前额叶区域。
  • 纳曲酮减弱观看负性图片时腹内侧前额叶皮层、丘脑和尾状核的激活。
  • 与安慰剂相比,纳曲酮改变观看情绪面孔时腹内侧前额叶活动及右侧运动前区和额极等活动。
  • 纳曲酮增加观看恐惧面孔时左侧额中回活动。

临床怎么用

  • 结果提示阿片系统可能作为自动情绪调节的潜在靶点,但尚需临床人群验证。

局限性

  • 未来研究应探索剂量反应效应、κ-阿片受体贡献以及临床人群中是否可见类似结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We need to identify novel, tractable therapeutic targets for anxiety disorders. Converging evidence suggests the endogenous opioid system plays a role in modulating affective processing, but its contribution to regulation of threat processing in humans remains unclear. AIMS: We investigated the neural correlates of non-specific opioid antagonism on explicit and implicit regulation of threatening stimuli in healthy volunteers, using functional magnetic resonance imaging (fMRI). METHOD: In a randomised, double-blind, placebo-controlled, crossover design, 38 healthy participants received the opioid antagonist naltrexone (50 mg) or placebo before completing two tasks during fMRI: (a) a cognitive emotional reappraisal task probing explicit regulation and (b) a face-viewing task probing implicit processing. RESULTS: Contrary to our hypothesis, we found naltrexone reduced distress ratings during the reappraisal task (p = 0.044) without impairing regulation success. Explicit regulation in the reappraisal task engaged lateral prefrontal regions similarly across drug conditions. However, naltrexone attenuated ventromedial prefrontal cortex, thalamus and caudate activation when viewing negative images. Naltrexone additionally altered ventromedial prefrontal cortex activity and in task-positive regions including right premotor area and frontal pole compared with placebo when viewing emotional faces. In particular, naltrexone increased left middle frontal gyrus activity when viewing fearful faces. CONCLUSIONS: Our results support a role for opioid signalling in automatic emotional regulation, but not in explicit regulation. Furthermore, naltrexone appeared to diminish activity in task-positive regions in response to emotional faces. These findings are consistent with a model where endogenous opioids 'fine-tune' affective responses to both negative and positive stimuli. Future research should explore dose-response effects, kappa-opioid contributions and whether similar results are seen in clinical populations.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Huneke NTM, van Steenbergen H, Fagan HA, et al. Effects of opioid antagonism on functional MRI correlates of explicit and implicit threat processing in healthy volunteers. Br J Psychiatry. 2026. PMID: 41986925. doi:10.1192/bjp.2026.10605

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。